Opetusministeri J. Virolainen 13/4 1969

Kirje 13.4.1969

Exploración del área marina Supe - Pucusana efectuada durante los periodos 9-13 y 16-18 de agosto de 1965, a bordo del "Explorador"

Describe la exploración bio oceanografía efectuada a bordo del "Explorador" tuvo como principal objetivo el comportamiento de los cardúmenes de anchoveta y determinar desove, relacionándolos con los principales factores abioticos en la zona Supe - Pisco, hasta una distancia de 60 millas náuticas de ka cista, El crucero comprendió un rastreo entre Supe Callao - Pucusana con un total de 49 estaciones distribuidas en 6 perfiles y un zig zag costero.

'The Advocate' Resident Advocate Newsletter, April 2008, Vol. 13.

This tool of communication between the 2,500 members of the Resident Advocate Committee (RAC) Program and the State Long-Term Care Ombudsman is used to keep all volunteers informed of their roles and responsibilities as they carry out the duties of a resident advocate. The Advocate is provided to Resident Advocates on a quarterly basis.

[Grand Canyon] 13/8 -32

Kirje 13.8.1932

Organic Newsletter, November 13, 2007

A newsletter produced by Iowa Department of Agriculture and Land Stewardship, this information is all about Iowa growers, what is new, what is going on around Iowa for growing.

Pääministeri Johannes Virolainen 13/4 1966

Kirje

Riksdagsman Väinö Leskinen 13.10.1967

Kirje

Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93.

BACKGROUND: The International Breast Cancer Study Group (IBCSG) conducted two complementary randomized trials to assess whether a treatment-free gap during adjuvant chemotherapy influenced outcome. PATIENTS AND METHODS: From 1993 to 1999, IBCSG Trials 13-93 and 14-93 enrolled 2215 premenopausal and postmenopausal women with axillary node-positive, operable breast cancer. All patients received cyclophosphamide (Cytoxan, C) plus either doxorubicin (Adriamycin, A) or epirubicin (E) for four courses followed immediately (No Gap) or after a 16-week delay (Gap) by classical cyclophosphamide, methotrexate, and fluorouracil (CMF) for three courses. The median follow-up was 7.7 years. RESULTS: The Gap and No-Gap groups had similar disease-free survival (DFS) and overall survival (OS). No identified subgroup showed a statistically significant difference, but exploratory subgroup analysis noted a trend towards decreased DFS for Gap compared with No Gap for women with estrogen receptor (ER)-negative tumors not receiving tamoxifen, especially evident during the first 2 years. CONCLUSIONS: A 16-week gap between adjuvant AC/EC and CMF provided no benefit and may have increased early recurrence rates in patients with ER-negative tumors.

Discours de M. de Lamalle, procureur impérial près le tribunal de 1ère instance de Sancerre, 13 janvier 1870. [Puis] Adieu / M. A. Turquet

Comprend : Adieu

Proclamation du roi (Charles X. 13 juin 1830)

[Acte royal. 1830-06-13]